Back to Search
MARGARET LAMMERT, MD
Emergency Medicine Physician
NPI: 1083175020IndividualAccepts Medicare
Specialties, Licenses & Credentials
Emergency Medicine PhysicianPrimary
Emergency Medicine
Code: 207P00000X
320997(NY)
Education
EMORY UNIVERSITY SCHOOL OF MEDICINE
Class of 2019
Research & Publications (20)
Vitamin D deficiency associated with number of neurofibromas in neurofibromatosis 1.
PMID 16571643·J Med Genet·2006
8-other
Prevalence of neurofibromatosis 1 in German children at elementary school enrollment.
PMID 15655144·Arch Dermatol·2005
8-other
Do hormonal contraceptives stimulate growth of neurofibromas? A survey on 59 NF1 patients.
PMID 15703081·BMC Cancer·2005
8-other
[Health economic consequences of insulin analogues in the treatment of type 1 diabetes in Denmark].
PMID 18433583·Ugeskr Laeger·2008
8-other
Cost-effectiveness of intensified versus conventional multifactorial intervention in type 2 diabetes: results and projections from the Steno-2 study.
PMID 18443195·Diabetes Care·2008
8-other
An economic assessment of analogue basal-bolus insulin versus human basal-bolus insulin in subjects with type 1 diabetes in the UK.
PMID 17407646·Curr Med Res Opin·2007
4-observational
Examining correlates of treatment satisfaction for injectable insulin in type 2 diabetes: lessons learned from a clinical trial comparing biphasic and basal analogues.
PMID 17286868·Health Qual Life Outcomes·2007
4-observational
Early primary tooth eruption in neurofibromatosis 1 individuals.
PMID 17850432·Eur J Oral Sci·2007
8-other
Comments on Long-term clinical and cost outcomes of treatment with biphasic insulin aspart 30/70 versus insulin glargine in insulin-naïve type 2 diabetes patients: cost-effectiveness analysis in the UK setting.
PMID 16709318·Curr Med Res Opin·2006
8-other
Multivariate models of health-related utility and the fear of hypoglycaemia in people with diabetes.
PMID 16870077·Curr Med Res Opin·2006
8-other
Long-term clinical and cost outcomes of treatment with biphasic insulin aspart 30/70 versus insulin glargine in insulin naïve type 2 diabetes patients: cost-effectiveness analysis in the UK setting.
PMID 16368057·Curr Med Res Opin·2005
4-observational
Overview of costs of stroke from published, incidence-based studies spanning 16 industrialized countries.
PMID 15881472·Curr Med Res Opin·2005
6-review
Decreased bone mineral density in patients with neurofibromatosis 1.
PMID 15988556·Osteoporos Int·2005
8-other
The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making.
PMID 15324513·Curr Med Res Opin·2004
8-other
Urinary alpha1-microglobulin excretion as biomarker of renal toxicity in trichloroethylene-exposed persons.
PMID 14986001·Int Arch Occup Environ Health·2004
8-other
What impact would pancreatic beta-cell preservation have on life expectancy, quality-adjusted life expectancy and costs of complications in patients with type 2 diabetes? A projection using the CORE Diabetes Model.
PMID 15324517·Curr Med Res Opin·2004
8-other
Validation of the CORE Diabetes Model against epidemiological and clinical studies.
PMID 15324514·Curr Med Res Opin·2004
4-observational
Comparing the long-term cost-effectiveness of repaglinide plus metformin versus nateglinide plus metformin in type 2 diabetes patients with inadequate glycaemic control: an application of the CORE Diabetes Model in type 2 diabetes.
PMID 15324515·Curr Med Res Opin·2004
4-observational
Deleterious effects of increased body weight associated with intensive insulin therapy for type 1 diabetes: increased blood pressure and worsened lipid profile partially negate improvements in life expectancy.
PMID 15324518·Curr Med Res Opin·2004
8-other
Renal cell cancer risk and occupational exposure to trichloroethylene: results of a consecutive case-control study in Arnsberg, Germany.
PMID 12594774·Am J Ind Med·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 450 CLARKSON AVE
BROOKLYN, NY 11203 - Phone
- (718) 270-4580
Quick Facts
- NPI
- 1083175020
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile